Natriuretic peptide receptor‐C‐mediated attenuation of vascular smooth muscle cell hypertrophy involves Gqα/PLCβ1 proteins and ROS‐associated signaling

By  

Pharmacology Research & Perspectives, Vol. 6, Iss. 1, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacological interference of vascular smooth muscle cell hypertrophy induced by glycosylated human oxyhaemoglobin

By Peiro C.   Vallejo S.   Nevado J.   Angulo J.   Llergo J.L.   Cercas E.   Rodrguez-Manas L.   Sanchez-Ferrer C.F.  

European Journal of Pharmacology, Vol. 386, Iss. 2, 1999-12 ,pp. : 317-321

Elsevier

Access to resources Recommend Favorite

Deoxyribozymes as Inhibitors of Vascular Smooth Muscle Cell Growth

By  

Current Pharmaceutical Biotechnology, Vol. 5, Iss. 4, 2004-08 ,pp. : 337-339

Bentham Science Publishers

Access to resources Recommend Favorite

The role of the mitochondrion in smooth muscle cell fate choices of proliferation versus apoptosis during vascular and cardiovascular diseases

By Clark J.F.   Kranc K.R.  

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 4, 1999-12 ,pp. : 513-525

Informa Healthcare

Access to resources Recommend Favorite

Role of the lipoxygenase pathway in phenylephrine-induced vascular smooth muscle cell proliferation and migration

By Nishio E.   Watanabe Y.  

European Journal of Pharmacology, Vol. 336, Iss. 2, 1997-10 ,pp. : 267-273

Elsevier

Access to resources Recommend Favorite